 |
|
 
|
|
|
| Agensys |
$42,800,000 |
| AGY Therapeutics |
$31,300,000 |
| Alkermes |
$46,000,000 |
| Amylin Pharmaceuticals |
$100,000,000 |
| Ariad Pharmaceuticals |
$46,000,000 |
| AtheroGenics, Inc. |
$20,600,000 |
| Caliper Technologies |
$110,400,000 |
| Censtor |
$20,900,000 |
| Centene |
$18,000,000 |
| Cephalon |
$125,000,000 |
| Cephalon |
$45,000,000 |
| Corgentech |
$50,400,000 |
| DAOU Systems |
$12,000,000 |
| Darwin |
$30,000,000 |
| Durect |
$20,000,000 |
| DUSA Pharmaceuticals |
$42,750,000 |
| Gene Logic |
$20,000,000 |
| Genentech |
$72,500,000 |
| Genesoft |
$21,800,000 |
| Gensia |
$80,000,000 |
| Gensia |
$26,300,000 |
| Genzyme |
$36,800,000 |
| HealthCentral |
$22,000,000 |
| IGEN |
$25,000,000 |
| Insite Vision |
$8,800,000 |
| Intermune |
$27,300,000 |
| Invitrogen |
$172,500,000 |
| Khepri Pharmaceuticals |
$11,000,000 |
| LogistiCare |
$20,000,000 |
| Martek Biosciences |
$20,300,000 |
| Martek Biosciences |
$10,000,000 |
| Maxim |
$20,600,000 |
| Myogen, Inc. |
$66,400,000 |
| Neocrin |
$16,000,000 |
| NetGenics |
$17,700,000 |
| Paradigm Genetics |
$28,000,000 |
| Protein Design Labs, Inc. |
$150,000,000 |
| ReGen Biologics |
$8,600,000 |
| Repligen |
$45,000,000 |
| Ribi ImmunoChem |
$12,000,000 |
| Saegis Pharmaceuticals |
$30,000,000 |
| Sciquest.com |
$37,500,000 |
| Selfcare |
$41,500,000 |
| Signal Pharmaceuticals |
$12,000,000 |
| Skila Inc. |
$26,100,000 |
| Synergen |
$52,500,000 |
| Targeted Genetics, Inc. |
$30,300,000 |
| Targeted Genetics, Inc. |
$17,500,000 |
| The Liposome Company, Inc. |
$15,000,000 |
| Therion |
$10,500,000 |
| Transgenomic |
$12,000,000 |
| Transkaryotic Therapies |
$15,600,000 |
| Valentis, Inc. |
$19,200,000 |
| Xenon Genetics |
$44,900,000 |
| |
|
| *Transactions completed by principals, including those completed at other firms. |
|
|
|
|
|
